Archive

Category: Alzheimer

AbbVie Receives $20M Milestone in its DUB Targets Collaboration with Mission to Treat Alzheimer and Parkinson Diseases

Shots: AbbVie selects two DUB targets to advance it to the next stage of drug discovery based on the results from in vitro & in vivo studies for which Mission will receive a $20M as milestones As per 2018 agreement, the companies collaborated to identify novel DUB targets and discover associated inhibitor compounds for neurodegenerative […]

reMYND Commences P-l Study of RES19-T for Alzheimer’s Disease

Shots: The P-l trial will evaluate the safety, tolerability, and PK of ReS19-T for the treatment of AD. In preclinical studies, ReS19-T has shown to robustly restore synaptic plasticity with an acute response and improve inflammation and AD pathology over a longer treatment duration reMYND has a broad pipeline of novel programs in development, with […]